Interleukin-6 trans-signaling in inflammatory bowel disease.
about
Interleukin-6 affects cell death escaping mechanisms acting on Bax-Ku70-Clusterin interactions in human colon cancer progressionSTAT3 and sphingosine-1-phosphate in inflammation-associated colorectal cancerIL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancerFood allergy alters jejunal circular muscle contractility and induces local inflammatory cytokine expression in a mouse model.Dietary phenethylisothiocyanate attenuates bowel inflammation in mice.Interleukin-6 trans-signalling differentially regulates proliferation, migration, adhesion and maspin expression in human prostate cancer cellsPeripheral blood gene expression patterns discriminate among chronic inflammatory diseases and healthy controls and identify novel targetsSkeletal muscle catabolism in trinitrobenzene sulfonic acid-induced murine colitis.Catheterization of intestinal loops in ruminants does not adversely affect loop function.The IL-6 response to Chlamydia from primary reproductive epithelial cells is highly variable and may be involved in differential susceptibility to the immunopathological consequences of chlamydial infectionThe pathogenicity of an enteric Citrobacter rodentium Infection is enhanced by deficiencies in the antioxidants selenium and vitamin E.Ferrous sulfate, but not iron polymaltose complex, aggravates local and systemic inflammation and oxidative stress in dextran sodium sulfate-induced colitis in rats.IL6 secreted by Ewing sarcoma tumor microenvironment confers anti-apoptotic and cell-disseminating paracrine responses in Ewing sarcoma cells.Expression and Regulation of Transcription Factor FoxA2 in Chronic Rhinosinusitis With and Without Nasal Polyps.Cardiac lineage protein-1 (CLP-1) regulates cardiac remodeling via transcriptional modulation of diverse hypertrophic and fibrotic responses and angiotensin II-transforming growth factor β (TGF-β1) signaling axis.Impacts of Salmonella enterica Serovar Typhimurium and Its speG Gene on the Transcriptomes of In Vitro M Cells and Caco-2 Cells.Inflammation: a way to understanding the evolution of portal hypertension.Human oral isolate Lactobacillus fermentum AGR1487 induces a pro-inflammatory response in germ-free rat colonsThe serum IL-6 profile and Treg/Th17 peripheral cell populations in patients with type 1 diabetes.Targeted regulation of a lymphocyte-endothelial-interleukin-6 axis by thermal stress.S-glutathionylation impairs signal transducer and activator of transcription 3 activation and signaling.Effect of glucans from Caripia montagnei mushroom on TNBS-induced colitis.Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel disease.IL-6/IL-6R as a potential key signaling pathway in prostate cancer development.Targeting interleukins for the treatment of inflammatory bowel disease-what lies beyond anti-TNF therapy?From physiology to disease and targeted therapy: interleukin-6 in inflammation and inflammation-associated carcinogenesis.Intestinal barrier dysfunction: implications for chronic inflammatory conditions of the bowel.Interleukin-6 (IL-6) serum concentrations in dogs with hepatitis and hepatic tumours compared with those with extra-hepatic inflammation and tumours.Interleukin (IL) 1beta induction of IL-6 is mediated by a novel phosphatidylinositol 3-kinase-dependent AKT/IkappaB kinase alpha pathway targeting activator protein-1.Effects of Rhizophora mangle on Experimental Colitis Induced by TNBS in Rats.Bifidobacterium lactis attenuates onset of inflammation in a murine model of colitis.Long-term selenium deficiency increases the pathogenicity of a Citrobacter rodentium infection in mice.Interleukin-6 is essential for zwitterionic polysaccharide-mediated abscess formation.Anti-inflammatory effects of pomegranate (Punica granatum L.) husk ellagitannins in Caco-2 cells, an in vitro model of human intestine.Mice with Inflammatory Bowel Disease are Susceptible to Clostridium difficile Infection With Severe Disease Outcomes.New insights into the immunological effects of food bioactive peptides in animal models of intestinal inflammation.Significance of serum Il-9 levels in inflammatory bowel disease.Increased inflammation and lethality of Dusp1-/- mice in polymicrobial peritonitis models.Spontaneous in vitro IL-6 production in various intestinal segments in patients with inflammatory bowel disease
P2860
Q24596148-DED64CED-3015-4F88-84E7-D5F8E1F1CE51Q26998940-138BFF5D-37EC-422A-A773-82E95E71E030Q29614594-AC89E700-D7DD-443D-A5ED-5385B24F05B9Q33446429-87138C77-55A6-46F8-B3CB-53AB49437910Q33566354-7E68A08A-BBE6-40D6-B339-CCDCE7C7E790Q33690450-F043C78D-27BD-44B9-B695-304F306CC1FEQ33869998-EE21A075-A1EF-44F5-AAFF-1C53477B390CQ34137976-3D854FB9-FFDB-4CC1-A7AA-BF86CC5874FBQ34406990-82FC1C44-D12D-44DC-AF68-4CA0467C2A90Q34478462-E126725A-2DCE-4C20-B784-78632660F6EFQ34740127-F789D9D6-9745-4065-B26C-71333C7FE72CQ35596454-00432F16-A4D2-4B5C-BC62-C9EB39A40F45Q35717574-DDFA76F9-D710-4D71-A607-07BF15FED5DFQ35872129-AB5D0A12-43BC-4D97-ADF4-0A01ABEA4BF2Q35921700-078F1DAB-7FAB-4623-B5A1-F5DCE0840EC6Q35985683-08DE10FA-F3BF-43A9-A885-AD660660C7D3Q36391634-C5392E6B-70B6-4FC9-9F89-E3A35B5FFFABQ36542517-D39D3FAC-F5FE-42DF-A044-825FB9444A3CQ36679011-05728381-203B-4A0F-A3BB-EF2FC479AF1CQ37063499-D3ACEE8D-71C7-4B16-B53B-BBEC642FDA00Q37125937-CDF806A0-9894-4E90-B1A0-9D186E7F6B7EQ37645197-1E164CA0-0A08-4D68-87B8-DC6FB61C5002Q37692380-BB4D8335-2719-45E5-8D33-FBE99BDC7D1FQ37968599-6A2B365D-88C0-4768-BC62-AC639995966FQ38172801-2F6DE92D-ACCE-4E8D-83C0-89863FA20557Q38336406-53D6CB58-0758-4D0B-9C59-E9F78C9296BFQ38810502-C63D47A2-5E78-4B99-AF6D-BD06B60DB670Q41917838-0D91A834-024C-4F2B-9302-45DA45BCF16AQ42010475-836A8D6E-352B-408A-8533-FF9B5A42ACDDQ42097592-BFD184AE-5BD4-4656-97D8-D35110D3EACFQ42580341-FF12046E-DB43-4E44-997A-2E5EDD18C005Q43601759-64A0E889-81F4-4B78-A321-DBFB95DD15DBQ45110147-C63CD921-67A5-4AE3-A944-350B027E0C0CQ47577758-5DEDEF41-DBB9-4B99-A679-EF7C4A9CD05CQ50026548-FA811F29-FD7B-4453-A13E-F5B967EF3AE8Q50571787-9AFE13FC-5CC4-4A8A-B9BC-93936C54D7FFQ52916530-07D4F0B3-B1E6-40CF-A97D-F0CBD9D78A1EQ54667180-4389678A-8283-49D0-A9EC-9F78E6512E4DQ57121540-83AD4C19-D9DB-4A55-88A8-D75EAD88D3EF
P2860
Interleukin-6 trans-signaling in inflammatory bowel disease.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Interleukin-6 trans-signaling in inflammatory bowel disease.
@ast
Interleukin-6 trans-signaling in inflammatory bowel disease.
@en
Interleukin-6 trans-signaling in inflammatory bowel disease.
@nl
type
label
Interleukin-6 trans-signaling in inflammatory bowel disease.
@ast
Interleukin-6 trans-signaling in inflammatory bowel disease.
@en
Interleukin-6 trans-signaling in inflammatory bowel disease.
@nl
prefLabel
Interleukin-6 trans-signaling in inflammatory bowel disease.
@ast
Interleukin-6 trans-signaling in inflammatory bowel disease.
@en
Interleukin-6 trans-signaling in inflammatory bowel disease.
@nl
P921
P1476
Interleukin-6 trans-signaling in inflammatory bowel disease.
@en
P2093
Keiichi Mitsuyama
Michio Sata
P304
P356
10.1016/J.CYTOGFR.2006.09.003
P577
2006-10-12T00:00:00Z